BiliaryTractCancer near Hudson, FL

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Biography: Dr. Grogan received his PhD in Pharmacology and MD from the University of Kansas School of Medicine. He then completed an Internal Medicine Residency followed by a Physician-Scientist Training Program/Medical Oncology Fellowship (Neuro-Oncology Track) at the University of Wisconsin Hospitals and Clinics. Dr. Grogan joins Moffitt from the University of Wisconsin School of Medicine and Public Health, where he was a Faculty Clinical Instructor in Neuro-Oncology and Medical Oncology, Department of Medicine, and a Research Associate and Postdoctoral Research Fellow in the Department of Oncology, McArdle Laboratory for Cancer Research.Dr. Groganspecializes in the management of central nervous system malignancies, with a focus on treating patients with primary CNS cancers including both low- and high-grade gliomas. Hisclinical interests include precision and individualized treatment strategies for patientswith high-grade gliomaswhile also focusing heavily on quality-of-life considerations.

Care Philosophy: Dr Michelle Echevarria is an Assistant Member in the Department of Radiation Oncology. Dr Echevarria received her Medical Degree at Ponce School of Medicine, Ponce, Puerto Rico, and her Master of Science in Molecular Medicine at the University of South Florida. Dr Echevarria recently completed a Radiation Oncology Residency at Moffitt Cancer Center/University of South Florida, where she also served as Chief Resident. Dr Echevarria's clinical interests include the use of advanced radiation techniques such as intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) in the treatment of head and neck cancers.

Care Philosophy: Dr Vogelbaum is an internationally known leader in neurosurgical oncology and a distinguished investigator in laboratory research, translational and clinical trials in gliomas. Dr Vogelbaum is currently Chief of Neurosurgery and Program Leader of the Department of Neuro-Oncology at Moffitt Cancer Center. He has served on or led numerous scientific committees and holds an array of honors and awards, as well as leadership positions at the regional, national, and international levels. He is the principal investigator and co-investigator of a broad range of early-phase investigator-initiated therapeutic trials, both national and international multisite collaborative studies. He has published over 190 peer-reviewed and invited articles.

Care Philosophy: Dr Enas Abdallah is an Assistant Member in the Moffitt Cancer Center Department of Malignant Hematology. Dr Abdallah earned her MD from Ain Shams University in Cairo, Egypt. She completed an Internal Medicine Residency at Henry Ford Allegiance Health and a Geriatric Medicine Fellowship at Beaumont Health in Michigan. Dr Abdallah's clinical and scholarly interests are focused on inpatient management of malignant hematology patients. She will work closely with all members of the inpatient team to optimize care and outcomes.

Care Philosophy: Dr John Mullinax is an Associate Member in the Sarcoma Department and Immunology Department of Moffitt Cancer Center and Associate Professor in the Department of Surgery at the University of South Florida Morsani College of Medicine. He is the Surgical Director of the Cellular Immunotherapy Program and the Associate Program Director for the Complex General Surgical Oncology fellowship at Moffitt. Dr Mullinax is board-certified in both Surgery and Complex General Surgical Oncology by the American Board of Surgery. Dr Mullinax's primary clinical focus is the surgical management of patients with soft tissue sarcoma throughout the body, to include retroperitoneal sarcoma and gastrointestinal stromal tumors.

Care Philosophy: Dr Bejanyan is an Associate Member, Program Leader of Blood and Marrow Transplant (BMT) and Head of the Leukemia/Myeloid Section of the BMT and Cellular Immunotherapy Department at Moffitt Cancer Center. She is an Associate Professor in Oncologic Sciences at the University of South Florida.Dr Bejanyan also served as the Clinical Scientific Co-Director of Moffitt Pharmacokinetics and Pharmacodynamics Core. As a physician investigator with clinical and research expertise in BMT and cellular immunotherapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), Dr Bejanyan focuses in advancing clinical and translational research by fostering innovative immune cell therapy strategies to treat leukemia.

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Locke is a medical oncologist and translational researcher in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. He leads the Immune Cell Therapy (ICE-T) initiative at Moffitt, an integrated cross-departmental translational team. Dr Locke is a clinical research leader in the field of Chimeric Antigen Receptor (CAR) T cell therapy, acting as a national P.I. for several pivotal trials of anti-CD19 CARs for lymphoma. In addition, Dr Locke is translating findings from his laboratory into new cellular immunotherapies such as the Moffitt created whole protein survivin tumor vaccine for multiple myeloma. Dr Locke graduated with a B.S.

Care Philosophy: Dr Melissa Anne Mallory is a Breast Surgical Oncologist at Moffitt Cancer Center. She attended the University of Virginia for both her undergraduate and graduate studies where she received a Distinguished Major's in Biology (BS) followed by a Doctor of Medicine (MD). Dr Mallory completed her surgical residency at Harvard's Brigham and Women's Hospital in Boston, MA and a R25 fellowship in Multidisciplinary Image-Guided Therapy focusing on image-guided innovations for breast surgical operations at the National Center for Image-Guided Therapy and the Brigham and Women's Hospital/Harvard Medical School. Following residency, Dr Mallory completed a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York.

Care Philosophy: Dr David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr Sallman's clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center.

Care Philosophy: Dr Isenalumehe earned her MD from Sophie Davis School of Biomedical Education, CUNY Medical College, City College of New York (BA/MD Program) / Albany Medical College, New York and her MS degree in Clinical and Biomedical Investigation from the University of Southern California, Los Angeles. She completed a combined Internal Medicine and Pediatric Residency at NJMS-Rutgers (former: University of Medicine and Dentistry of New Jersey, Newark, where she also served as Internal Medicine-Pediatrics Chief Resident. She completed a Pediatric Hematology-Oncology Fellowship at Children's Hospital of Los Angeles, University of Southern California, where she also served as Chief Fellow.

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Voss received an MD from the Ohio State University College of Medicine and an MPH in Epidemiology from the University of Texas Health Sciences Center at Houston. She completed a General Surgery Residency at the University of California San Diego Medical Center, and most recently completed a Complex General Surgical Oncology Fellowship at the University of Texas MD Anderson Cancer Center. Dr Voss's clinical interests include extremity sarcomas, complex retroperitoneal and abdominal sarcomas, GISTs, and adrenal tumors (both benign and malignant).

Care Philosophy: Dr. McNamee is Board Certified in General Surgery and he specializes in General and Advanced Laparoscopic Surgery. He currently serves as the Chief Medical Officer at Florida Hospital Zephyrhills. During his many years at Florida Hospital, he has served in positions such as Chief of Staff Elect, Chief of Surgery and Chairman of the Medical Staff Quality Review Committee at Florida Hospital Zephyrhills. He is a Fellow of the American College of Surgeons (FACS).

Care Philosophy: Dr Ankita Patel is anAssistant Member with Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza.Dr Patel received her MBBS degree from Smt. N.H.L. Municipal Medical College in Ahmedabad, India. She completed an internal medicine residency at the University of Illinois College of Medicine. After completing her residency, she was employed at Hospital Physician Services of Central Alabama as a Hospitalist. Dr Patel most recently completed a Hematology-Oncology Fellowship at the University of New Mexico.

Care Philosophy: Dr Jennifer Eatrides is a member of the Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. Dr Eatrides earned her MD degree with a research focus at the University of South Florida Morsani College of Medicine. She completed an Internal Medicine Residency and completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center. Dr Eatrides has a particular interest in hematologic malignancies. The MMG faculty at TGH provides invaluable medical oncology services to the large patient population of this leading regional hospital.

Care Philosophy: Dr Sharjeel Hooda is a Clinical Instructor-Member in the Moffitt Cancer Center Department of Satellite and Community Oncology. Dr Hooda is based at Moffitt International Plaza (MIP). Dr Hooda earned his MD and MS in Clinical Research at Emory University, Atlanta, Georgia. He completed an Internal Medicine Residency at Cleveland Clinic in Ohio where he also served as Chief Resident in Quality and Patient Safety. Dr Hooda completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center he also served as Chief Quality Fellow in Medicine.